SNDX – syndax pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $41.00 price target on the stock.
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum [Yahoo! Finance]
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum
Form ARS Syndax Pharmaceuticals For: Dec 31
Form DEFA14A Syndax Pharmaceuticals
Form DEF 14A Syndax Pharmaceuticals For: Mar 27
Form 8-K Syndax Pharmaceuticals For: Mar 15
Form S-3ASR Syndax Pharmaceuticals
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.